Jasmine Naru | CANCER PROTEOMICS | Women Researcher Award

Posted on by ScienceFather

Dr. Jasmine Naru | CANCER PROTEOMICS | Women Researcher Award

Staff Scientist at Fred Hutch Cancer Center, United States

Jasmine Naru is a dedicated biological researcher with a robust background in various biological disciplines, including proteomics, molecular biology, biochemistry, and genetics. She earned her Ph.D. in Biochemistry from Panjab University, India, in 2016, and has since been associated with prestigious research institutions. Currently a Staff Scientist at the Fred Hutchinson Cancer Center in Seattle, WA, Jasmine has contributed significantly to the field of cancer research, particularly focusing on acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Her innovative research approaches aim to enhance risk stratification and therapeutic targeting for these conditions. Jasmine’s work has resulted in multiple publications in high-impact journals, showcasing her expertise and commitment to advancing the understanding of cancer biology.

Professional Profile

Education

Jasmine Naru’s educational journey reflects her commitment to biological research and academic excellence. She completed her Bachelor of Science in Life Sciences with a focus on Zoology, Botany, and Chemistry at Guru Nanak Dev University in 2006. She pursued her Master of Science in Human Genetics, graduating in 2008 from the same institution. Jasmine then advanced her studies at Panjab University, where she earned her Ph.D. in Biochemistry in 2016. Her doctoral research focused on protein profiling in retinoblastoma patients, utilizing mass spectrometry-based proteomics to identify potential biomarkers. This solid educational foundation has equipped her with the necessary knowledge and skills to excel in her research endeavors.

Professional Experience

Jasmine Naru has gained extensive professional experience in the field of biological research. She began her career as a Junior Research Fellow at the Post Graduate Institute of Medical Education and Research (PGIMER) in India in 2010. Her journey continued at Panjab University, where she served as a Junior and Senior Research Fellow until 2016. Following her academic tenure, Jasmine transitioned to the Fred Hutchinson Cancer Center in Seattle as a Postdoctoral Research Fellow, focusing on innovative cancer research projects from 2017 to 2023. Recently, she has taken on the role of Staff Scientist at Fred Hutch, where she develops novel approaches for risk stratification and therapeutic targeting in AML and MDS. Her professional trajectory showcases her dedication to advancing cancer research and her ability to lead impactful projects.

Research Interests

Jasmine Naru’s research interests are centered on advancing the understanding of hematological malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). She focuses on the development of innovative strategies for risk stratification and targeted therapy, employing proteomic and genomic approaches to identify novel biomarkers that can enhance patient outcomes. Her work encompasses the use of iPSC-derived cell lines to explore the biology of MDS and the development of immunotherapy techniques for myeloid malignancies. Jasmine is passionate about translating her research findings into clinical applications that can significantly improve the lives of patients facing these challenging diseases, making her a valuable contributor to the field of cancer research.

Research Skills

Jasmine Naru possesses a comprehensive set of research skills that enhance her capabilities as a biological researcher. Her technical proficiency includes advanced techniques in proteomics, such as mass spectrometry (ESI-MS/MS, MALDI-TOF/TOF), as well as quantitative analysis methods like iTRAQ and TMT. Jasmine is adept at using bioinformatics tools for pathway analysis and has experience in various molecular biology techniques, including PCR, ELISA, Western blotting, and flow cytometry. Additionally, she has strong analytical skills, enabling her to interpret complex data effectively. Jasmine’s multitasking abilities and collaborative approach allow her to thrive in fast-paced research environments, making her an asset to any scientific team.

Awards and Honors

Throughout her academic and professional career, Jasmine Naru has received several honors and recognitions for her contributions to the field of biological research. Notably, she was awarded the Junior Research Fellowship from the Indian Council of Medical Education and Research (ICMR) during her early research career, which provided her with essential support to pursue her doctoral studies. Her commitment to excellence is reflected in her successful publication record, with multiple first-author articles in high-impact journals. Jasmine’s research efforts have also been acknowledged through various project grants, such as the SWOG Impact Award and NIH/NIDDK funding, highlighting her contributions to advancing cancer research and her potential for future impactful work.

Conclusion

Overall, Jasmine Naru is a strong candidate for the Best Researcher Award. Her exceptional research experience in oncology, strong technical skills, and noteworthy publication record make her a highly deserving contender. Expanding her work’s breadth and obtaining more independent funding could further solidify her position as a top researcher in her field. Her dedication and scientific contributions already position her as a standout researcher with a clear impact in the scientific community.

Publication Top Note

  1. Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
    • Authors: Pogosova-Agadjanyan, E.L., Hua, X., Othus, M., Meshinchi, S., Stirewalt, D.L.
    • Year: 2023
    • Journal: Biomarker Research
    • Volume: 11
    • Issue: 1
    • Page: 31
    • Citations: 0
  2. Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
    • Authors: Termini, C.M., Moseley, A., Othus, M., Meshinchi, S., Stirewalt, D.L.
    • Year: 2023
    • Journal: Haematologica
    • Volume: 108
    • Issue: 11
    • Pages: 3148–3151
    • Citations: 2
  3. Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome
    • Authors: Clough, C.A., Pangallo, J., Sarchi, M., Bradley, R.K., Doulatov, S.
    • Year: 2022
    • Journal: Blood
    • Volume: 139
    • Issue: 13
    • Pages: 2038–2049
    • Citations: 44
  4. AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: A SWOG report
    • Authors: Pogosova-Agadjanyan, E.L., Moseley, A., Othus, M., Meshinchi, S., Stirewalt, D.L.
    • Year: 2020
    • Journal: Biomarker Research
    • Volume: 8
    • Issue: 1
    • Page: 29
    • Citations: 23

 

 

Fatemeh Safari | Cancer Therapy | Women Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Fatemeh Safari | Cancer Therapy | Women Researcher Award

Associate Professor at University of Guilan, Iran

Dr. Fatemeh Safari is an accomplished academic and researcher currently serving as an Associate Professor at the University of Guilan, Iran. She holds a Ph.D. in Molecular & Cellular Biology from Hokkaido University, Japan, and has extensive postdoctoral experience at prestigious institutions, including the University of Tokyo and NAIST. Dr. Safari has made significant contributions to the field of microbiology and cancer research, with numerous publications in reputable journals and books. Her work explores the molecular mechanisms underlying cancer progression and treatment, focusing on the therapeutic potential of stem cell secretomes and natural compounds like green tea extracts. Awarded multiple fellowships, including the JSPS Fellowship and Monbukagakusho Scholarship, she has established herself as a leading researcher. Dr. Safari’s expertise is complemented by her commitment to mentoring students and her active involvement in academic collaborations. Her research continues to impact the scientific community, enhancing our understanding of cancer biology and potential therapies.

Profile

Education

Assistant Professor Dr. Fatemeh Safari holds a Ph.D. in Molecular & Cellular Biology from Hokkaido University in Sapporo, Japan, where she completed her degree in 2011. Prior to her doctoral studies, she earned a Master’s degree in Microbiology from the University of Tehran in 2005, further solidifying her foundational knowledge in the biological sciences. Dr. Safari began her academic journey with a Bachelor’s degree in Biology, obtained from the University of Shahid Beheshti in Tehran, Iran, in 1999. Her diverse educational background encompasses a strong focus on molecular and cellular mechanisms, equipping her with the expertise necessary for her research in cancer biology and regenerative medicine. Dr. Safari’s academic achievements reflect her commitment to advancing scientific knowledge and contributing to the fields of microbiology and molecular biology.

Professional Experience

Prof. Dr. Fatemeh Safari has extensive experience in academia and research. Currently, she serves as an Associate Professor at the University of Guilan, Iran, since September 2022, where she has made significant contributions to the field of Molecular and Cellular Biology. Prior to this role, she was an Assistant Professor at the same institution from September 2016 to 2022. Dr. Safari gained valuable research experience as a Postdoctoral Fellow at prestigious institutions in Japan, including NAIST from 2014 to 2015 and The University of Tokyo from 2012 to 2014. Earlier in her career, she worked as a Research Assistant at the University of Tehran from 2005 to 2007. Throughout her career, Dr. Safari has focused on innovative research in microbiology and cancer biology, publishing extensively in reputable journals and contributing to various collaborative research projects. Her academic journey reflects her dedication to advancing scientific knowledge and mentoring future generations of researchers.

Research Interest

Professor Dr. Fatemeh Safari’s research interests lie at the intersection of molecular and cellular biology, with a particular focus on cancer biology, stem cell therapy, and drug development. Her work delves into understanding the molecular mechanisms underlying cancer progression and the potential therapeutic effects of mesenchymal stem cell (MSC) secretomes on various cancer types, including breast and colon cancers. Dr. Safari’s research also explores the modulation of cellular signaling pathways by natural and synthetic compounds, aiming to develop innovative anti-cancer agents. Her investigations into molecular docking, drug synthesis, and the bioactivity of green tea extracts highlight her commitment to finding novel therapeutic approaches. Additionally, she is involved in the development of advanced methodologies, such as spheroid formation and co-culture systems, to study tumor microenvironments. Dr. Safari’s research is highly interdisciplinary, contributing to the fields of oncology, pharmacology, and biotechnology.

Research Skills

Prof. Dr. Fatemeh Safari possesses a diverse array of research skills that significantly contribute to her expertise in molecular and cellular biology. Her extensive experience in microbiology and cancer research equips her with a robust foundation in experimental design and methodology. Proficient in advanced techniques such as molecular docking, cell culture, and the development of in vitro cancer models, she adeptly investigates cellular signaling pathways and the effects of various compounds on cancer cell behavior. Dr. Safari’s analytical skills are demonstrated through her numerous publications, showcasing her ability to synthesize complex data and draw meaningful conclusions. Additionally, her familiarity with both traditional and innovative approaches in microbiology allows her to explore interdisciplinary research opportunities. As a result, she is not only a proficient researcher but also a valuable mentor to emerging scientists, fostering a collaborative and innovative research environment in her laboratory.

Award and Recognition

Prof. Dr. Fatemeh Safari is a distinguished academic in the field of Molecular & Cellular Biology, recognized for her significant contributions to cancer research. She holds a Ph.D. from Hokkaido University and has garnered prestigious fellowships, including the Monbukagakusho Scholarship and the Japan Society for the Promotion of Science Fellowship. As an Associate Professor at the University of Guilan, she has published over 30 research articles in reputable journals and co-authored several book chapters, focusing on the molecular mechanisms of cancer and the therapeutic potential of stem cell secretomes. Her innovative research has earned her recognition within the academic community, and she actively participates in international conferences, sharing her findings and insights. Prof. Dr. Safari’s dedication to advancing scientific knowledge, coupled with her mentorship of emerging researchers, underscores her impactful role in the scientific community, making her a deserving candidate for the Best Researcher Award.

Conclusion

Professor Dr. Fatemeh Safari is a distinguished academic and researcher in the field of Molecular & Cellular Biology, with significant contributions to cancer research and regenerative medicine. Her extensive educational background, including a Ph.D. from Hokkaido University, complements her impressive publication record, featuring numerous articles in reputable journals. As an Associate Professor at the University of Guilan, she has demonstrated leadership in academia while mentoring students and collaborating on innovative research projects. Dr. Safari’s research focuses on the therapeutic potential of human adipose-derived mesenchymal stem cells (hAMSCs) in cancer treatment, highlighting her commitment to advancing scientific knowledge. Her recognition through prestigious fellowships, such as the JSPS Fellowship, underscores her international standing in the scientific community. With her blend of expertise, experience, and a dedication to research excellence, Professor Dr. Fatemeh Safari is a strong candidate for the Best Researcher Award, embodying the qualities of a leading scholar in her field.

Publication Top Notes
  1. Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways
    • Authors: Rasouli, M., Alavi, M., D’Angelo, A., Roudi, R., Safari, F.
    • Year: 2024
    • Journal: International Immunopharmacology
    • Volume/Page: 143, 113265
    • Citations: 0
  2. Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents
    • Authors: Aghahosseini, F., Bayat, M., Sadeghian, Z., Gheidari, D., Safari, F.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume/Issue/Page: 19(9), e0306973
    • Citations: 0
  3. TCAA-promoted novel approach synthesis and in vitro anti-cancer activity evaluation of spiro[indolo[2,1-b]quinazoline-6,4′-pyrano[2,3-c]pyrazole]-5′-carboxamides
    • Authors: Sadeghian, Z., Bayat, M., Eskandari, M., Safari, F.
    • Year: 2024
    • Journal: Results in Chemistry
    • Volume/Page: 9, 101636
    • Citations: 1
  4. The suppression of cell motility through the reduction of FAK activity and expression of cell adhesion proteins by hAMSCs secretome in MDA-MB-231 breast cancer cells
    • Authors: Safari, F., Bararpour, S., Omidi Chomachaei, F.
    • Year: 2024
    • Journal: Investigational New Drugs
    • Volume/Issue/Page: 42(3), pp. 272–280
    • Citations: 1
  5. Regulation of Cellular-Signaling Pathways by Mammalian Proteins Containing Bacterial EPIYA or EPIYA-Like Motifs Predicted to be Phosphorylated
    • Authors: Rasouli, M., Safari, F., Sobhani, N., Alavi, M., Roudi, R.
    • Year: 2024
    • Journal: DNA and Cell Biology
    • Volume/Issue/Page: 43(2), pp. 74–84
    • Citations: 1
  6. IRTKS Elevation in Patients with Colon Cancer and the Curative Influences of Hamsc Secretome on Polarity and Invasion of HT-29 Colon Cancer Cells
    • Authors: Khodabandeh, A., Safari, F., Ebadi Zavieh, S., Mirzanejad, L.
    • Year: 2024
    • Journal: Regenerative Engineering and Translational Medicine
    • Citations: 0
  7. Harnessing Nanotechnology for Idarubicin Delivery in Cancer Therapy: Current Approaches and Future Perspectives
    • Authors: Safari, F., Jalalian, Y., Abdouss, H., Fathi-Karkan, S., Pandey, S.
    • Year: 2024
    • Journal: BioNanoScience
    • Citations: 2
  8. Synthesis, Molecular Docking, and Biological Evaluation of Pyridin-3-yl-Pyrimidin-2-yl-Triazole Derivatives as Anti-cancer Agents
    • Authors: Firoozpour, L., Moghimi, S., Fallah Barzegar, M.H., Safari, F., Foroumadi, A.
    • Year: 2024
    • Journal: Polycyclic Aromatic Compounds
    • Volume/Issue/Page: 44(3), pp. 2062–2076
    • Citations: 1
  9. Synthesis and Biological Evaluation of 12-Aryl-11-hydroxy-5,6-dihydropyrrolo[2″,1″:3′,4′]pyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-8(9H)-one Derivatives as Potential Cytotoxic Agents
    • Authors: Barghi Lish, A., Foroumadi, A., Kolvari, E., Safari, F.
    • Year: 2023
    • Journal: ACS Omega
    • Volume/Issue/Page: 8(45), pp. 42212–42224
    • Citations: 1
  10. Evaluation of SgK269 expression in colon cancer patients and the effects of hAMSCs secretome on tumor invasion through SgK269/c-Src/p-P130Cas/p-Paxillin/p-ERK1/2 signaling pathway in HT-29 colon cancer cells
    • Authors: Safari, F., Ansari Dogaheh, F., Dadashi, H.
    • Year: 2023
    • Journal: 3 Biotech
    • Volume/Issue/Page: 13(11), 346
    • Citations: 1

 

 

Ranal Gurbanov | Cancer Research | Best Researcher Award

Posted on by ScienceFather

Mr. Ranal Gurbanov | Cancer Research | Best Researcher Award

Medical Student at Gazi University School of Medicine, Turkey.

Ranal Gurbanov, an Azerbaijani national born on May 2, 2004, is a promising young individual with a strong academic and humanitarian profile. He earned a bronze medal in the 2019 National Biology Olympiad and participated in the Future Leaders Exchange Program (FLEX) in the U.S., gaining valuable cultural and leadership experiences. Ranal has been recognized for academic excellence by the Baku Department of Education and is actively involved in community service through the “Social and Active Doctors Community (GÜTSAH)” and “KANOPE Blood and Organ Donation Community.” These roles demonstrate his commitment to supporting children with chronic diseases and raising awareness about blood and organ donation. Additionally, Ranal has pursued specialized medical training from prestigious institutions such as the University of Pennsylvania and Acıbadem University. His profile reflects a blend of academic achievement, leadership, and dedication to public health, though he would benefit from further research contributions to strengthen his candidacy for awards.

Profile:

Education

Ranal Gurbanov’s education reflects a strong commitment to academic excellence and personal growth. He began his educational journey with notable achievements at Baku High School No:102, where his exceptional talents earned him an Academic Excellence Award from the Baku Department of Education in 2021. Following this, Ranal participated in the Future Leaders Exchange Program (FLEX), which provided him with an opportunity to study at an American high school and experience a different educational and cultural environment. His commitment to furthering his knowledge is evident in his enrollment in various specialized medical training programs. These include “Vital Signs: Understanding What the Body Is Telling Us” by the University of Pennsylvania, “Clinical Terminology for International and U.S. Students” by the University of Pittsburgh, and several clinical risk management and forensic medicine courses offered by Acıbadem University. This diverse educational background highlights his dedication to both academic and practical learning.

Professional Experience

Ranal Gurbanov has actively engaged in various professional and extracurricular roles that reflect his commitment to both academic excellence and community service. He earned a bronze medal in the 2019 National Biology Olympiad, demonstrating his strong foundational knowledge in biology. His participation in the Future Leaders Exchange Program (FLEX) allowed him to study in the U.S., gaining invaluable cultural and leadership experience. In his volunteer work, Ranal has contributed to the “Social and Active Doctors Community (GÜTSAH),” where he helps improve the lives of children with chronic diseases through moral support and gifts. Additionally, his role in the “KANOPE” Blood and Organ Donation Community showcases his efforts to raise awareness about organ and blood donation, addressing critical healthcare issues in Turkey. His involvement in various medical training programs further highlights his dedication to understanding and improving clinical practices.

Research Interest

Ranal Gurbanov’s research interests are rooted in the intersection of biology, medical ethics, and community health. His early achievements in the National Biology Olympiad reflect a strong foundation in biological sciences, while his academic journey has been enriched by global experiences through the FLEX program, which broadened his understanding of diverse health systems. Ranal’s current focus includes exploring the ethical dimensions of organ donation and transplantation, a field he actively engages in through his role in the “KANOPE Blood and Organ Donation Community.” His interest also extends to clinical risk management and forensic medicine, evidenced by his participation in specialized training programs. Ranal is particularly motivated by addressing public health challenges and improving patient care through innovative approaches. His commitment to community service, coupled with his academic pursuits, underscores a desire to integrate scientific research with practical applications in healthcare.

Research Skills

Ranal Gurbanov has demonstrated a strong foundation in research through his participation in diverse educational and community activities. His involvement in the National Biology Olympiad and subsequent achievements highlight his solid grasp of biological sciences and scientific inquiry. Ranal’s engagement in specialized medical training programs, such as “Vital Signs” and “Clinical Risk Management,” reveals his commitment to understanding complex clinical concepts and research methodologies. Additionally, his role in organizing blood and organ donation awareness campaigns reflects his ability to translate scientific knowledge into public health initiatives. Although his profile is more focused on community service and humanitarian work, these experiences have honed his skills in communication, project management, and ethical considerations in healthcare. To further enhance his research skills, Ranal could benefit from direct involvement in scientific research projects and publications, which would solidify his expertise and contribute to his development as a researcher.

Award and Recognition

Ranal Gurbanov has received notable awards and recognition for his exceptional achievements and contributions. In 2019, he earned a bronze medal at the National Biology Olympiad organized by the Azerbaijan Ministry of Education, highlighting his early excellence in biological sciences. His leadership and adaptability were further recognized when he won the Future Leaders Exchange Program (FLEX) scholarship, allowing him to study in the U.S. and experience diverse cultural values. Additionally, he was honored with the Academic Excellence Award by the Baku Department of Education in 2021 for his outstanding academic performance at Baku High School No:102. Ranal’s commitment to social causes is evident through his active roles in the “Social and Active Doctors Community (GÜTSAH)” and the “KANOPE Blood and Organ Donation Community,” where he has contributed significantly to public health awareness and support for patients with chronic conditions.

Conclusion

Ranal Gurbanov shows tremendous potential and passion, especially in humanitarian and community-driven projects. However, to be a strong candidate for the Best Researcher Award, he needs to enhance his research output and demonstrate more direct contributions to the scientific field through publications or significant research findings. His commitment to learning and social impact is commendable, and with further academic and research development, he could emerge as a future contender.

Publication Top Notes

Ovatodiolide Inhibits Endometrial Cancer Stemness via Reactive Oxygen Species-Mediated DNA Damage and Cell Cycle Arrest

  • Journal: Chemico-Biological Interactions
  • Year: 2024
  • DOI: 10.1016/j.cbi.2024.111244
  • Authors: Chun-Yu Chen, Yu-Zhen Ye, Yu-Hao Huang, Yew-Min Tzeng, Ranal Gurbanov, Wen-Ling Wang, Wen-Wei Chang

 

Jaclyn Gellings | Breast Cancer | Best Researcher Award

Posted on by ScienceFather

Dr. Jaclyn Gellings | Breast Cancer | Best Researcher Award

Surgical Research Resident at Medical College of Wisconsin, United States

Jaclyn Gellings, MD, is a distinguished General Surgery Resident and Global Surgery Research Fellow at the Medical College of Wisconsin. She holds a BS from the University of Wisconsin and an MD from the Medical College of Wisconsin. Gellings has garnered notable accolades, including the Condon Donegan Research Award and the MCWAH Research and Quality Award, reflecting her research excellence. Her work focuses on trauma care and surgical procedures, with significant publications and grant-funded projects. She actively participates in global health initiatives, including fellowships and rotations in Nepal and Ireland, demonstrating her commitment to improving healthcare worldwide. Gellings is also engaged in professional societies and has held leadership roles, contributing to the advancement of her field. Her extensive research, international experience, and leadership make her a standout candidate for the Researcher Award, showcasing her dedication to medical innovation and global health improvement.

Profile

Education

Jaclyn Gellings, MD, has a distinguished educational background that underscores her commitment to medicine and surgery. She earned her Bachelor of Science degree from the University of Wisconsin-Madison in May 2015, where she laid the foundation for her medical career. Following her undergraduate studies, she pursued her Doctor of Medicine degree at the Medical College of Wisconsin, graduating in May 2020. Her educational journey continued with advanced postgraduate training as a General Surgery Resident at the Medical College of Wisconsin, where she has been honing her clinical and research skills since July 2020. Currently, she is further advancing her expertise through a Global Surgery Research Fellowship at the same institution, set to conclude in June 2025. This extensive educational experience has equipped Dr. Gellings with a robust clinical acumen and a strong research focus, positioning her as a leading figure in her field.

Professional Experience

Jaclyn Gellings, MD, currently serves as a General Surgery Resident and Global Surgery Research Fellow at the Medical College of Wisconsin. Her postgraduate training includes a residency in General Surgery and a prestigious fellowship in Global Surgery Research, focusing on trauma and acute care. Dr. Gellings has received notable awards such as the Condon Donegan Research Award and the MCWAH Research and Quality Award, underscoring her research excellence. Her work has been supported by significant grants, including a $49,823 grant for characterizing surgical paths for uninsured patients. She has been involved in various leadership roles, including serving as a Resident Board Member for the Wisconsin Medical Society and a member of the Global Affairs Committee for the Association for Academic Surgery. Her research contributions are well-recognized, with numerous peer-reviewed publications and presentations at national and international conferences.

Research Interest

Jaclyn Gellings, MD, focuses her research on trauma and acute care surgery, with particular interest in optimizing surgical practices and improving patient outcomes. Her work encompasses various aspects of trauma care, including the cost-effectiveness of diagnostic testing and the impact of prophylactic treatments. Gellings is also dedicated to global health, exploring surgical needs and interventions in underserved regions such as Nepal and Ireland. Her research extends to the implementation of evidence-based guidelines in trauma care and the evaluation of surgical procedures like the Norwood procedure in pediatric cardiology. Through her Global Surgery Research Fellowship, Gellings aims to advance surgical care on an international scale, addressing disparities and enhancing the quality of care in diverse settings. Her contributions reflect a commitment to both clinical excellence and global health improvement, demonstrating a comprehensive approach to advancing the field of surgery.

Research Skills

Jaclyn Gellings, MD, demonstrates exceptional research skills through her comprehensive and impactful work in the field of surgery. Her expertise spans clinical research, evidenced by her significant contributions to trauma and acute care surgery, including cost-saving initiatives and procedural improvements. Gellings excels in designing and conducting studies that address critical healthcare challenges, as reflected in her peer-reviewed publications and competitive research grants. Her role in the Global Surgery Research Fellowship highlights her proficiency in managing and executing research projects on an international scale. Additionally, her experience with various research methodologies, from clinical trials to data analysis, underscores her versatility and depth of knowledge. Gellings’ ability to communicate complex findings through invited lectures and peer-reviewed presentations further illustrates her strong analytical skills and commitment to advancing medical science. Her well-rounded research capabilities are complemented by her leadership in academic and professional societies, reinforcing her status as a leading researcher in her field.

Award and Recognition

Jaclyn Gellings, MD, has garnered notable awards and recognition throughout her medical and research career. She received the 2022 Condon Donegan Research Award and the MCWAH Research and Quality Award for her impactful research contributions. Gellings also earned the Maryann Zwaska Schmitz Endowed Scholarship Fund for Surgery in 2020 and multiple scholarships during her time at the University of Wisconsin, Madison. Her dedication to research and academic excellence is further highlighted by her Honors in Research from the Medical College of Wisconsin. As an active member of professional societies, including the Eastern Association for the Surgery of Trauma and the Association for Academic Surgery, she has been acknowledged for her leadership and commitment to advancing surgical practice. Gellings’ global health initiatives and significant research funding further underscore her exceptional contributions to the field.

Conclusion

Jaclyn Gellings is a highly qualified candidate for the Researcher Award, given her strong research background, significant contributions to the field of surgery, and active role in global health initiatives. Her achievements reflect a deep commitment to improving surgical care and addressing global health challenges. By expanding her publication impact and engaging in broader collaborations, she can further strengthen her position as a leading researcher. Overall, her record of accomplishment and dedication make her a compelling candidate for this prestigious award.

Publication Top Notes

  • Thoracic cavity irrigation prevents retained hemothorax and decreases surgical intervention in trauma patients
    • Authors: Al Tannir, A.H., Biesboer, E.A., Golestani, S., De Moya, M.A., Carver, T.W.
    • Journal: Journal of Trauma and Acute Care Surgery
    • Year: 2024
    • Volume and Issue: 97(1), pp. 90–95
  • Benign mature teratoma of the cecum: A case report
    • Authors: Gellings, J., Nimmer, K., Doucette, S., Johnson, S.C., Kothari, A.N.
    • Journal: Journal of Surgical Case Reports
    • Year: 2023
    • Volume and Issue: 2023(12), rjad674
  • Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens
    • Authors: Gellings, J.A., Cortina, C.S., Jorns, J.M., Huang, C.-C., Kong, A.L.
    • Journal: American Journal of Surgery
    • Year: 2023
    • Volume and Issue: 225(2), pp. 304–308
  • Norwood Procedure—Difficulty in Weaning From Cardiopulmonary Bypass and Implications for Outcomes
    • Authors: Gellings, J.A., Johnson, W.K., Ghanayem, N.S., Kuhn, E.M., Woods, R.K.
    • Journal: Seminars in Thoracic and Cardiovascular Surgery
    • Year: 2020
    • Volume and Issue: 32(1), pp. 119–125
    • Citations: 2
  • Design considerations in coiled-coil fusion constructs for the structural determination of a problematic region of the human cardiac myosin rod
    • Authors: Andreas, M.P., Ajay, G., Gellings, J.A., Rayment, I.
    • Journal: Journal of Structural Biology
    • Year: 2017
    • Volume and Issue: 200(3), pp. 219–228
    • Citations: 3

 

Jaydira Del Rivero | Medical Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Jaydira Del Rivero | Medical Oncology | Best Researcher Award

MD of NCI/NIH, United States.

Dr. Jaydira Del Rivero has a robust set of research skills tailored for oncology. Her expertise includes cell culture, immunohistochemistry, CRISPR/Cas9 gene editing, and advanced microscopy. Proficient in data analysis using SPSS and R, she excels in bioinformatics for genomic data. Dr. Del Rivero is adept at experimental design, critical literature evaluation, and communicating scientific results.

Professional Profiles:

Education

Dr. Jaydira Del Rivero earned her Doctor of Medicine (MD) degree from the University of Veracruz, Faculty of Medicine “Lic. Miguel Aleman Valdez” in October 2003. She completed her Internal Medicine residency at Woodhull Medical and Mental Health Center/NYU Langone Medical Center in Brooklyn, NY, from July 2008 to June 2011. Following this, she pursued a fellowship in Endocrinology, Diabetes, and Metabolism at the Inter-Institute Adult Endocrine Training Program at the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, from July 2011 to June 2014. Dr. Del Rivero further specialized in Medical Oncology through a fellowship at the National Cancer Institute, National Institutes of Health, Bethesda, MD, from July 2015 to June 2017. Her extensive training reflects her deep commitment to advancing in both endocrinology and oncology.

Professional Experience

Dr. Jaydira Del Rivero has held several notable positions in the medical field. She began her career as a Medical Officer at the National Institute of Child Health and Human Development from August 2014 to June 2015, where she focused on endocrine research. Following her fellowship in Medical Oncology, she joined the National Cancer Institute (NCI) as a Clinical Fellow in the Medical Oncology Branch from July 2015 to June 2017. Since 2017, Dr. Del Rivero has been a Medical Oncologist at the NCI, specializing in the treatment and research of cancer. Her role involves clinical practice, patient management, and contributing to ongoing research efforts. Dr. Del Rivero’s work is pivotal in advancing the understanding and treatment of oncology-related conditions.

Research Interest

Dr. Jaydira Del Rivero’s research interests are centered around oncology, with a particular focus on advancing the understanding and treatment of cancer. Her work primarily explores endocrine-related malignancies, including the development of novel therapeutic strategies and treatment protocols. Dr. Del Rivero is involved in researching the mechanisms of cancer progression and resistance to treatments, aiming to improve patient outcomes through innovative approaches. Her research also encompasses the evaluation of new drugs and treatment regimens, with a commitment to integrating clinical findings with experimental data to enhance therapeutic efficacy. Through her work at the National Cancer Institute, she contributes to cutting-edge studies that aim to address critical challenges in cancer care and therapy.

Award and Honors

Dr. Jaydira Del Rivero has received several notable awards and honors for her contributions to oncology research. She was recognized with the prestigious NCI Director’s Award in 2021 for her exceptional work in cancer research and her commitment to advancing treatment options. In 2019, she earned the American Association for Cancer Research (AACR) Scholar Award, which acknowledged her innovative research on endocrine-related cancers. Additionally, Dr. Del Rivero was honored with the National Cancer Institute’s Outstanding Research Award in 2018 for her impactful studies on novel therapeutic strategies. Her achievements reflect her dedication to improving cancer care and her significant contributions to the field of oncology.

 Research Skills

Dr. Jaydira Del Rivero possesses advanced research skills essential for her work in oncology. She is proficient in various laboratory techniques including cell culture, immunohistochemistry, and molecular cloning. Her expertise extends to cutting-edge methods such as CRISPR/Cas9 gene editing and advanced microscopy techniques. Dr. Del Rivero is skilled in data analysis and statistical software such as SPSS and R, which she utilizes for interpreting complex research data. She also has experience with bioinformatics tools for genomic data analysis, enabling her to identify novel biomarkers and therapeutic targets. Her research skills are complemented by a strong ability to design and conduct experiments, critically evaluate scientific literature, and effectively communicate findings through publications and presentations.

Publications
  1. Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity
    Authors: E Wong, LS Rosen, M Mulay, A VanVugt, M Dinolfo, C Tomoda, …
    Journal: Thyroid
    Year: 2007
    Volume/Issue: 17 (4), 351-355
    Citations: 238
  2. The Bethesda handbook of clinical oncology
    Authors: J Abraham, JL Gulley
    Publisher: Lippincott Williams & Wilkins
    Year: 2022
    Citations: 158
  3. Anti–PD-L1 treatment induced central diabetes insipidus
    Authors: C Zhao, SH Tella, J Del Rivero, A Kommalapati, I Ebenuwa, J Gulley, …
    Journal: The Journal of Clinical Endocrinology & Metabolism
    Year: 2018
    Volume/Issue: 103 (2), 365-369
    Citations: 104
  4. Tyrosine kinase inhibitor–induced thyroid disorders: a review and hypothesis
    Authors: N Makita, T Iiri
    Journal: Thyroid
    Year: 2013
    Volume/Issue: 23 (2), 151-159
    Citations: 99
  5. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors
    Authors: AM Rosenberg, P Friedmann, J Del Rivero, SK Libutti, AM Laird
    Journal: Surgery
    Year: 2016
    Volume/Issue: 159 (1), 302-310
    Citations: 93
  6. Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis/hyperostosis‐hyperphosphatemia syndrome
    Authors: MS Ramnitz, P Gourh, R Goldbach‐Mansky, F Wodajo, S Ichikawa, …
    Journal: Journal of Bone and Mineral Research
    Year: 2016
    Volume/Issue: 31 (10), 1845-1854
    Citations: 87
  7. The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and/or unresectable pheochromocytoma and paraganglioma
    Authors: L Fishbein, J Del Rivero, T Else, JR Howe, SL Asa, DL Cohen, PLM Dahia, …
    Journal: Pancreas
    Year: 2021
    Volume/Issue: 50 (4), 469-493
    Citations: 77
  8. Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome
    Authors: R Därr, J Nambuba, J Del Rivero, I Janssen, M Merino, M Todorovic, …
    Journal: Endocrine-Related Cancer
    Year: 2016
    Volume/Issue: 23 (12), 899-908
    Citations: 76
  9. Endocrine‐related adverse events related to immune checkpoint inhibitors: Proposed algorithms for management
    Authors: J Del Rivero, LM Cordes, J Klubo‐Gwiezdzinska, RA Madan, LK Nieman, …
    Journal: The Oncologist
    Year: 2020
    Volume/Issue: 25 (4), 290-300
    Citations: 72
  10. Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report
    Authors: JE Faris, AF Moore, GH Daniels
    Journal: Thyroid
    Year: 2007
    Volume/Issue: 17 (11), 1147-1149
    Citations: 72